Everything below concerns clinical evidence. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-09-19. Where a claim depends on a specific study, the study is described rather than over-claimed.
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
| Property | Value | Notes |
|---|---|---|
| Molecular weight | About 1419.5 Da | Calculated from the fifteen-residue sequence |
| Residue count | 15 amino acids | Single-letter sequence GEPPPGKPADDAGLV |
| Compound class | Synthetic peptide | Produced by solid-phase synthesis |
| Synonyms | BPC 157; pentadecapeptide BPC 157 | Naming varies across suppliers and papers |
| Appearance | White to off-white powder | Typical form of the lyophilized material |
Dry powder is generally stored at low temperature, with minus twenty degrees Celsius or colder advised for extended retention. Reconstituted solutions are less stable than the solid form and are normally kept cold and shielded from repeated freeze-thaw cycles. Light exposure is avoided because some peptides degrade under ultraviolet radiation. The exact rate of degradation depends on concentration, pH, and the presence of salts, so a single shelf life does not apply to every preparation. Reported stability figures should be read as indicative of typical handling rather than as universal constants.
Confirmation of identity and purity relies on standard peptide analysis techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and serves as the most common purity assay. Mass spectrometry, often coupled to that chromatography step, provides an accurate molecular mass that can be matched against the expected value. Amino acid analysis or sequencing can be added for further confirmation. Because short peptides can be produced by different synthetic routes, laboratories usually report both a chromatographic purity percentage and a mass confirmation rather than a single figure.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
The first full DNA genome to be sequenced was that of bacteriophage φX174 in 1977. Medical Research Council scientists deciphered the complete DNA sequence of the Epstein-Barr virus in 1984, finding it contained 172,282 nucleotides. Completion of the sequence marked a significant turning point in DNA sequencing because it was achieved with no prior genetic profile knowledge of the virus. A non-radioactive method for transferring the DNA molecules of sequencing reaction mixtures onto an immobilizing matrix during electrophoresis was developed by Herbert Pohl and co-workers in the early 1980s. Followed by the commercialization of the DNA sequencer "Direct-Blotting-Electrophoresis-System GATC 1500" by GATC Biotech, which was intensively used in the framework of the EU genome-sequencing programme, the complete DNA sequence of the yeast Saccharomyces cerevisiae chromosome II. Leroy E. Hood's laboratory at the California Institute of Technology announced the first semi-automated DNA sequencing machine in 1986. This was followed by Applied Biosystems' marketing of the first fully automated sequencing machine, the ABI 370, in 1987 and by Dupont's Genesis 2000 which used a novel fluorescent labeling technique enabling all four dideoxynucleotides to be identified in a single lane. By 1990, the U.S. National Institutes of Health (NIH) had begun large-scale sequencing trials on Mycoplasma capricolum, Escherichia coli, Caenorhabditis elegans, and Saccharomyces cerevisiae at a cost of US$0.75 per base.
== Fictional character biography == Thomas A. Anderson was born in Lower Downtown, Capital City, USA on March 11, 1962, according to his criminal record, or September 13, 1971 according to his passport (both seen in the film). His mother was Michelle McGahey (the name of the first film's art director) and his father was John Anderson. He attended Central West Junior High and Owen Patterson High (named after the film's production designer). In high school, he excelled at science, math and computer courses, and displayed an aptitude for literature and history. Although he had disciplinary troubles when he was thirteen to fourteen years old, Anderson went on to become a respected member of the school community through his involvement in football and hockey. At the start of the series, Neo is one of billions of humans neurally connected to the Matrix, unaware that the world he lives in is a simulated reality.
== Description == Croton lechleri belongs to the family Euphorbiaceae and are medium-sized trees with evergreen foliage, growing 10 to 20 meters (33 to 66 ft) in height. Despite their relatively large height, the trees have very narrow trunks, averaging a bole diameter of about 30 centimeters (0.98 feet). The leaves are large, alternate cordate (heart-shaped), bright green and 15–30 cm in width and length. The flowers are greenish-white, white or amber, which produce small, three-part capsule fruits that appear on a thin spike that measures 30–50 cm. Both the smooth, mottled bark and viscous, red, latex-rich resin excreted from the wounded trunk of the tree are used medicinally.[9] While the sap can be harvested with a tap much like natural latex from rubber trees, trees that are repeatedly tapped become vulnerable to fungal infections. Croton lechleri are native to the Amazon basin and are distributed across the tropical regions of the South American countries of Bolivia, Brazil, Colombia, Ecuador, Peru, and Venezuela. They are most commonly found in the northwest lowlands between sea level up to 1000 m in elevation, mostly in mineral-rich disturbed soil and along rivers.
In 1944, Jones became the first Black-American to become a member of the American Society of Refrigeration Engineers. 1953 Merit Award, Phyllis Wheatley Auxiliary (Phillis Wheatley Club of Cleveland, Ohio), "for outstanding achievements which serve as an inspiration to youth." In 1977, he was posthumously inducted into the Minnesota Inventors Hall of Fame. In 1991, the National Medal of Technology was awarded to Joseph A. Numero and Frederick M. Jones. President George Bush presented the awards posthumously to their widows at a ceremony in the White House Rose Garden. Jones was the first Black American to receive the award. In 1996, the Thermo King Model 'C' refrigeration unit, the world's first front-mount refrigeration unit for mobile trucks, was designated an International Mechanical Engineering Landmark by the American Society of Mechanical Engineers. Jones designed and built the prototype from junkyard salvage. The challenges were to build a structural frame and refrigerant tubing connections that would withstand the constant pounding of road vibrations. In 2007, Jones was inducted into the National Inventors Hall of Fame, which honored him as a "Visionary Veteran." In the March 2009 issue of Heavy Duty Truck magazine, editor Tom Berg dubbed Jones "The King of Cool", and wrote that his "technological breakthrough redefined the global marketplace, with cultural reverberations felt from the world's largest cities to its most isolated villages." In 2015, Jones' achievements were recognized by the creators of a Black heritage-themed playground located in Minneapolis.
In January 2022, to draw attention, the workers drove around Seoul with the message "Partners' are your biggest asset." Through this Starbucks Korea pledged to hire 1,600 more workers for the stores. Starbucks in Korea has started Siren Order, which is a service that makes online orders available. This has started in 2014, helping customers to order their drinks before their arrival, and picking them up as soon as they arrive. This service has led to nearly 5 million customers to register to the page. As there is high rise in orders, Starbucks in the United States, as well as Canada, Hong Kong, and the United Kingdom has added siren order to their service. To reduce carbon footprint, Starbucks stores in South Korea will be eliminating all single-use cups by 2025. Starbucks stores in Jeju Island will be leading this campaign by only using reusable cups in all 23 stores allocated in the island. The customers can either choose to use their own cups, or deposit 1000 won to use the reusable cups provided by the store. When the cup is returned, the deposit will be returned through cash, Starbucks card or HappyHabit Application points. The reusable cups will be collected and cleaned up by a professional cleaner company, reducing the usage of single-use cups. The reusable cups will also be up-cycled to other forms as well. Starbucks Korea has 870 cashless stores which is about 60% of the whole stores that are available in Korea. Due to this, there has been a reduction of people using cash from 4% in original stores to 0.5% in cashless stores.
Sources: en.wikipedia.org
=== Other explanations === In the UK, psychiatrist Kingsley Jones sees the support of the Board of Control as important in persuading psychiatrists to use insulin coma therapy. The treatment then acquired the privileged status of a standard procedure, protected by professional organizational interests. He also notes that it has been suggested that the Mental Treatment Act 1930 encouraged psychiatrists to experiment with physical treatments. British lawyer Phil Fennell notes that patients "must have been terrified" by the insulin coma therapy procedures and the effects of the massive overdoses of insulin, and were often rendered more compliant and easier to manage after a course. Leonard Roy Frank, an American activist from the psychiatric survivors movement who underwent 50 forced insulin coma treatments combined with ECT, described the treatment as "the most devastating, painful and humiliating experience of my life", a "flat-out atrocity" glossed over by psychiatric euphemism, and a violation of basic human rights. In 2013, French physician-and-novelist Laurent Seksik wrote a historical novel about the tragic life of Eduard Einstein: Le cas Eduard Einstein. He related the encounter between Dr Sakel and Mileva Maric, Albert Einstein's first wife (and Eduard's mother), and the way Sakel's therapy had been given to Eduard, who had schizophrenia.
The oldest known pills were made of the zinc carbonates hydrozincite and smithsonite. The pills were used for sore eyes and were found aboard the Roman ship Relitto del Pozzino, wrecked in 140 BC. The Berne zinc tablet is a votive plaque dating to Roman Gaul made of an alloy that is mostly zinc. The Charaka Samhita, thought to have been written between 300 and 500 AD, mentions a metal which, when oxidized, produces pushpanjan, thought to be zinc oxide. Zinc mines at Zawar, near Udaipur in India, have been active since the Mauryan period (c. 322 and 187 BC). The smelting of metallic zinc here, however, appears to have begun around the 12th century AD. One estimate is that this location produced an estimated million tonnes of metallic zinc and zinc oxide from the 12th to 16th centuries. Another estimate gives a total production of 60,000 tonnes of metallic zinc over this period. The Rasaratna Samuccaya, written in approximately the 13th century AD, mentions two types of zinc-containing ores: one used for metal extraction and another used for medicinal purposes.
=== Diet === People who follow the prescribed dietary treatment from birth may (but not always) have no symptoms. Their PKU would be detectable only by a blood test. People must adhere to a diet low in Phe for optimal brain development. Since Phe is necessary to synthesize most proteins, it is required for appropriate growth, but levels must be strictly controlled.
=== Reproduction === Due to its geographic ranges, arapaima's lifecycle is greatly affected by seasonal flooding. Various pictures show slightly different coloring owing to colour changes when they reproduce. The arapaima lays its eggs when water levels are low or beginning to rise. They build a nest about 50 cm (20 in) wide and 15 cm (5.9 in) deep, usually in muddy-bottomed areas. As the water rises, the eggs hatch and the offspring have the flood season from May to August in which to prosper, such that yearly spawning is regulated seasonally.
Sources: en.wikipedia.org
guanine-cytosine content Also abbreviated GC-content. The proportion of nitrogenous bases in a nucleic acid that are either guanine (G) or cytosine (C), typically expressed as a percentage. DNA and RNA molecules with higher GC-content are generally more thermostable than those with lower GC-content due to molecular interactions that occur during base stacking.
The head is as large as an ordinary flour barrel, and has the shape of a sea lion head. The neck, if the creature may be said to have a neck, is of the same diameter as the body. The mouth is on the underside of the head and is protected by two tentacle tubes about eight inches in diameter and about 30 feet long. These tubes resemble an elephant's trunk and obviously were used to clutch in a sucker like fashion any object within their reach. Another tube or tentacle of the same dimensions stands out on the top of the head. Two others, one on each side, protrude from beyond the monster's neck, and extend fully 15 feet along the body and beyond the tail. The tail, which is separated and jagged with cutting points for several feet, is flanked with two more tentacles of the same dimensions as the others and 30 feet long. The eyes are under the back of the mouth instead of over it. This specimen is so badly cut up by sharks and sawfish that only the stumps of the tentacles remain, but pieces of them were found strewn for some distance on the beach, showing that the animal had a fierce battle with its foes before it was disabled and beached by the surf. Grant describes the animal as having seven "tentacles" and a "tail". If the "tail" is interpreted as another tentacle, giving a total of eight, this would suggest an octopus as opposed to a decapod, such as the squid or cuttlefish. Furthermore, nothing in the description indicates the presence of the long feeding tentacles found in squid, as the "tentacles" are said to be of the same dimensions.
International Chemical Safety Card 1262 (2-methylpentane) Material Safety Data Sheet for Hexane National Pollutant Inventory – n-hexane fact sheet Phytochemica l database entry Center for Disease Control and Prevention Warning from National Safety Council "COMMON CHEMICAL AFFECTS AUTO MECHANICS" Australian National Pollutant Inventory (NPI) page "EPA does not consider n-hexane classifiable as a human carcinogen." Federal Register / Vol. 66, No. 71 / Thursday, 12 April 2001 / Rules and Regulations
Sources: en.wikipedia.org
It is a synthetic peptide. Its design was inspired by a fragment of a protein found in human gastric juice, but the fifteen-amino-acid molecule itself is made in a laboratory and is not a normal component of food or of human tissue in appreciable amounts.
The number is an internal laboratory designation from the research group that first described the fragment. It does not encode a molecular weight, a receptor target, or a measured biological effect, and it carries no meaning outside the naming history of the compound.
It contains fifteen amino acid residues and has a calculated mass of roughly 1419.5 daltons. That places it in the short-peptide range, well below the size of small proteins, which affects how it is synthesized, purified, and analyzed.
It is a synthetic fifteen-amino-acid peptide whose sequence matches part of a protein found in human gastric juice. It is made by chemical synthesis, not purified from tissue. The name derives from an early fragment label, not from a molecular weight.